title: Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib.
authors.affiliation: Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy, aiurlo@policlinico.mi.it.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Iurlo
authors.forename: Daniele
authors.initials: D
authors.lastname: Cattaneo
authors.forename: Leonardo
authors.initials: L
authors.lastname: Boiocchi
authors.forename: Nicola
authors.initials: N
authors.lastname: Orofino
authors.forename: Elisa
authors.initials: E
authors.lastname: Fermo
authors.forename: Agostino
authors.initials: A
authors.lastname: Cortelezzi
authors.forename: Umberto
authors.initials: U
authors.lastname: Gianelli
mesh_terms: D000368:Aged; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D008297:Male; D009570:Nitriles; D011086:Polycythemia / Q000175:diagnosis* / Q000188:drug therapy*; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000188:drug therapy*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases